No Insurance Required!
Click to Sign Up Today

A clinical research study at Lonestar Research in Dallas is seeking adults 18 to 75 with metabolic health concerns, with or at risk for metabolic dysfunction-associated steatohepatitis (MASH). Individuals may qualify if they have two or more metabolic risk factors such as obesity, high triglycerides, low HDL cholesterol, type 2 diabetes, or high blood pressure.

Mash

A Clinical Research Study is Seeking Adult Volunteers 18 to 75 Years Old with or At Risk for MASH Due to Two or More Metabolic Risk Factors.

RESEARCH STUDY

A Clinical Research Study is Seeking Adult Volunteers 18 to 75 Years Old with or At Risk for MASH Due to Two or More Metabolic Risk Factors.

A clinical research study at Lonestar Research in Dallas is seeking adults 18 to 75 with metabolic health concerns, with or at risk for metabolic dysfunction-associated steatohepatitis (MASH). Individuals may qualify if they have two or more metabolic risk factors such as obesity, high triglycerides, low HDL cholesterol, type 2 diabetes, or high blood pressure. Adults with suspected MASH must have at least one of the following: enhanced liver fibrosis, a liver biopsy consistent with MASH, or a FibroScan. FibroScan and liver scans can be performed on-site to determine eligibility.

Mash

Participants Receive

Study-related medical care at no cost
Study-related investigational medication at no cost
Reimbursement for time and travel may be available up to $9,625
No-cost FibroScan and liver scans to help determine eligibility

Participants Receive

Asset 1

Study-related medical care and invesitgational medication at no cost

Asset 2

Reimbursement for time and travel may be available up to $XXX

Asset 3

No-cost FibroScan and liver scans to help determine eligibility

You May Qualify If

You are 18 to 75 years old
Have at least two of the following metabolic risk factors: obesity, high triglycerides, reduced HDL cholesterol, type 2 diabetes, or high blood pressure
Have MASH or suspected MASH. Adults with suspected MASH must have at least 1 of the following: enhanced liver fibrosis, liver biopsy consistent with suspected MASH, or a FibroScan. FibroScan and liver scans can be performed on-site to help determine eligibility.
Have had a stable body weight for at least 6 months

To see if you are eligible, please complete the form to get in touch with the study team.

Your privacy is important to us. By completing the following pre-screener you agree to our Privacy Policy and Terms of Use, and agree that we may retain the personal information you provide and share it with personnel involved in the study, or otherwise as described in the Privacy Policy, and we or our affiliates may contact you by phone using automated technology or pre-recorded voicemail or other means including but not limited to text messages (standard messaging rates may apply) regarding research studies.

About Metabolic Dysfunction-Associated Steatohepatitis (MASH).

MASH is a liver condition linked to metabolic health issues such as type 2 diabetes, obesity, high blood pressure, high triglycerides, and low HDL cholesterol. Unlike conditions that cause pain and obvious symptoms, MASH often develops silently, meaning most people are unaware they have it until liver damage goes too far.

Join the Study to Potentially Help Advance Science for Those with MASH

Adults 18 to 75 with at least two of the following health concerns: obesity, high triglycerides, reduced HDL cholesterol, type 2 diabetes, or high blood pressure may qualify. Adults with suspected MASH must have had one of the following components: enhanced liver fibrosis, a liver biopsy consistent with MASH, or a FibroScan. FibroScan and liver scans can be performed on-site to determine eligibility.

By taking part, you’re contributing to important research that could help advance future MASH treatment options.  

Elixia’s Commitment to Our Research Studies

Elixia is dedicated to advancing medical research through clinical studies that support the development of innovative treatment options. Our research focuses on exploring new possibilities for individuals living with metabolic dysfunction-associated steatohepatitis.

You May Qualify If

  • You are 18 to 75 years old
  • Have at least two of the following metabolic risk factors: obesity, high triglycerides, reduced HDL cholesterol, type 2 diabetes, or high blood pressure
  • Have MASH or suspected MASH. Adults with suspected MASH must have at least 1 of the following: enhanced liver fibrosis, liver biopsy consistent with suspected MASH, or a FibroScan. FibroScan and liver scans can be performed on-site to help determine eligibility.
  • Have had a stable body weight for at least 6 months

To see if you are eligible, please complete the form to get in touch with the study team.

Your privacy is important to us. By completing the following pre-screener you agree to our Privacy Policy and Terms of Use, and agree that we may retain the personal information you provide and share it with personnel involved in the study, or otherwise as described in the Privacy Policy, and we or our affiliates may contact you by phone using automated technology or pre-recorded voicemail or other means including but not limited to text messages (standard messaging rates may apply) regarding research studies.

Current Study Locations

Lonestar, Dallas Tx

12606 Greenville Avenue, Suite 275,
Dallas, Texas 75243